Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes
- PMID: 29233916
- PMCID: PMC6429941
- DOI: 10.1126/scisignal.aan2392
Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes
Abstract
Adults older than 65 account for most of the deaths caused by respiratory influenza A virus (IAV) infections, but the underlying mechanisms for this susceptibility are poorly understood. IAV RNA is detected by the cytosolic sensor retinoic acid-inducible gene I (RIG-I), which induces the production of type I interferons (IFNs) that curtail the spread of the virus and promote the elimination of infected cells. We have previously identified a marked defect in the IAV-inducible secretion of type I IFNs, but not proinflammatory cytokines, in monocytes from older (>65 years) healthy human donors. We found that monocytes from older adults exhibited decreased abundance of the adaptor protein TRAF3 (tumor necrosis factor receptor-associated factor 3) because of its increased proteasomal degradation with age, thereby impairing the primary RIG-I signaling pathway for the induction of type I IFNs. We determined that monocytes from older adults also failed to effectively stimulate the production of the IFN regulatory transcription factor IRF8, which compromised IFN induction through secondary RIG-I signaling. IRF8 played a central role in IFN induction in monocytes, because knocking down IRF8 in monocytes from younger adults was sufficient to replicate the IFN defects observed in monocytes from older adults, whereas restoring IRF8 expression in older adult monocytes was sufficient to restore RIG-I-induced IFN responses. Aging thus compromises both the primary and secondary RIG-I signaling pathways that govern expression of type I IFN genes, thereby impairing antiviral resistance to IAV.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures
Similar articles
-
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.J Med Virol. 2021 Sep;93(9):5376-5389. doi: 10.1002/jmv.27050. Epub 2021 May 9. J Med Virol. 2021. PMID: 33913550 Free PMC article.
-
Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.Front Immunol. 2018 Dec 21;9:3070. doi: 10.3389/fimmu.2018.03070. eCollection 2018. Front Immunol. 2018. PMID: 30622542 Free PMC article.
-
Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.J Virol. 2020 Jun 16;94(13):e00099-20. doi: 10.1128/JVI.00099-20. Print 2020 Jun 16. J Virol. 2020. PMID: 32295922 Free PMC article.
-
Cytoplasm and Beyond: Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.J Virol. 2019 Apr 3;93(8):e02299-18. doi: 10.1128/JVI.02299-18. Print 2019 Apr 15. J Virol. 2019. PMID: 30760567 Free PMC article. Review.
-
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors.Cell Mol Immunol. 2021 Mar;18(3):539-555. doi: 10.1038/s41423-020-00602-7. Epub 2021 Jan 18. Cell Mol Immunol. 2021. PMID: 33462384 Free PMC article. Review.
Cited by
-
The amalgam of naive CD4+ T cell transcriptional states is reconfigured by helminth infection to dampen the amplitude of the immune response.Immunity. 2024 Aug 13;57(8):1893-1907.e6. doi: 10.1016/j.immuni.2024.07.006. Epub 2024 Aug 2. Immunity. 2024. PMID: 39096910
-
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.World J Pediatr. 2024 Apr;20(4):307-324. doi: 10.1007/s12519-023-00790-y. Epub 2024 Feb 6. World J Pediatr. 2024. PMID: 38321331 Free PMC article. Review.
-
Early cellular and molecular signatures correlate with severity of West Nile virus infection.iScience. 2023 Nov 2;26(12):108387. doi: 10.1016/j.isci.2023.108387. eCollection 2023 Dec 15. iScience. 2023. PMID: 38047068 Free PMC article.
-
Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration.Front Aging. 2023 Oct 13;4:1234572. doi: 10.3389/fragi.2023.1234572. eCollection 2023. Front Aging. 2023. PMID: 37900152 Free PMC article. Review.
-
Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children.EMBO Rep. 2023 Dec 6;24(12):e57912. doi: 10.15252/embr.202357912. Epub 2023 Oct 11. EMBO Rep. 2023. PMID: 37818799 Free PMC article.
References
-
- Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. MMWR Surveill Summ 63, 3–27 (2014). - PubMed
-
- Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K, Mortality associated with influenza and respiratory syncytial virus in the united states. JAMA 289, 179–186 (2003). - PubMed
-
- Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K, Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. Journal of Infectious Diseases 178, 53–60 (1998). - PubMed
-
- Pillai PS, Molony RD, Martinod K, Dong H, Pang IK, Tal MC, Solis AG, Bielecki P, Mohanty S, Trentalange M, Homer RJ, Flavell RA, Wagner DD, Montgomery RR, Shaw AC, Staeheli P, Iwasaki A, Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352, 463–466 (2016). - PMC - PubMed
-
- Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD, CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. The Journal of Immunology 180, 2562–2572 (2008). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials